首页 | 本学科首页   官方微博 | 高级检索  
检索        

NPC与MPV方案治疗晚期非小细胞肺癌的疗效比较
引用本文:刘健,魏于全,陈兆红.NPC与MPV方案治疗晚期非小细胞肺癌的疗效比较[J].华西医学,2003,18(1):9-10.
作者姓名:刘健  魏于全  陈兆红
作者单位:1. 四川大学华西医院教育部人类疾病生物治疗重点实验室与肿瘤中心,四川成都,610041
2. 德阳市人民医院肿瘤科
摘    要:目的:比较NPC与MPV方案治疗晚期非小细胞肺癌(NSCLC)的疗效。方法:64例晚期NSCLC患者采用NPC32例,采用Kaplan-Meier方法分析患者生存期。采用Cox比例风险模型分析影响预后的因素。结果:MPV组中位生存期为8个月,NPC组中位生存期12个月。两组生存期差异有显著性(P<0.005,0.001)化疗的毒副反应主要是胃肠道反应和骨髓抑制。结论:NPC比MPV能延长患者生存期,但并没有增加毒副反应。

关 键 词:非小细胞肺癌  药物治疗  NPC方案  MPV方案  预后
文章编号:1002-0179(2003)01-0009-02

Retrospective Comparison between NCP and MPV Protocls for Advanced Non-small Cell Lung Cancer
LIU Jian,WEI Yu-quan,CHEN Zhao-hong.Retrospective Comparison between NCP and MPV Protocls for Advanced Non-small Cell Lung Cancer[J].West China Medical Journal,2003,18(1):9-10.
Authors:LIU Jian  WEI Yu-quan  CHEN Zhao-hong
Abstract:Objective:To compare the theapeutic effects between NCP and MPV protocols for advanced non-small cell lung cancer(NSCLC).Methods:Sixty-four patieuts havin advanced non-small cell lung cancer,the NPC and MPV Kaplan Meier meehods,were adopted to studdy 32 patients in eachs respectively for the survival rate and the cox regression prognostic factors.Results:The overall median two-years survival time in the MPV group was 8 months,and 12 months in the NPC group.The major toxic effects of the two groups were gastrointerstinal tract reactions and myelosuppression.Conclusion:NPC chemotherapy can prolong the survival time more in patients with advanced NSCLC than MPV chemotherapy but without increasing its toxicity.
Keywords:Lung neoplasms/drug therapy  Carcimoma  non-small cell/drug therapy  NPC protocol  MPV protocots  Prognosis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号